Finance

The FDA just put a pause on a cutting-edge gene editing trial that hadn’t started yet — and the company’s stock is dropping (CRSP, VRTX)

Posted on

Visit Markets Insider for constantly updated market quotes for individual stocks, ETFs, indices, commodities and currencies traded around the world. Go Now!

Related Items:
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Most Popular

58.6K
Automotive

Comment Of The Day: Truth In Bragging Edition
Finance

Amazon poached 30 executives from Microsoft in the past 3 years — 6 times as many executives as the next lead poacher, Google (AMZN)
17.7K
Finance

The world’s most popular migrant routes, in maps
17.1K
Tech

1920+: Alternate history WWI shooter with friggin’ amazing concept art
16.0K
Tech

The Secret Life of Pets trailer: What do a bunny, snake and bulldog have in common?
14.5K
Tech

iPhone 6c specs, price and design revealed in huge new leak
14.4K
Tech

Galaxy S7 edge concept design has us craving the real thing
13.9K
Tech

LG G5: Meet the “Friends” accessories that work with LG’s new flagship
To Top